# Morphine sulfate

NDC: 0409-2022
Generic name: Morphine Sulfate
Labeler / Manufacturer: Hospira, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20250421

FDA application: NDA202515

## Active ingredients

- MORPHINE SULFATE: 50 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0409-2022"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0409-2022
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ee8057d1-ed12-4e18-9efa-d83504abf612